Switching from blonanserin oral tablets/powders to transdermal patches alleviates extrapyramidal symptoms in patients with schizophrenia: A 52-week open-label study
- Resource Type
- Article
- Source
- In
Progress in Neuropsychopharmacology & Biological Psychiatry 8 March 2022 113 - Subject
- Language
- ISSN
- 0278-5846